Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults. (April 2017)

• Record Type: Journal Article
• Authors: Rastogi, Deepa; Jung, Molly; Strizich, Garrett; Shaw, Pamela A.; Davis, Sonia M.; Klein, Oana L.; Penedo, Frank J.; Ries, Andrew L.; Daviglus, Martha L.; Moreiras, Juan J.; Salathe, Matthias A.; Celedón, Juan C.; Isasi, Carmen R.; Kaplan, Robert C.
• Is Part Of: Respiratory medicine. Volume 125(2017)
• Page Start: 72
• Page End: 81
• Publication Date: 2017-04
• Subjects: Asthma -- Obesity -- Hispanics -- Pulmonary function -- Inflammation; Chest -- Diseases -- Periodicals; Chest -- Diseases -- Great Britain -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory Tract Diseases -- Periodicals; Appareil respiratoire -- Maladies -- Périodiques; Thorax -- Maladies -- Périodiques; Appareil respiratoire -- Maladies -- Traitement -- Périodiques; Electronic journals; 616.2
• DOI: 10.1016/j.rmed.2017.03.003
• Languages: English
• ISSNs: 0954-6111

Abstract

Abstract: Rationale: Obesity-related asthma is associated with higher disease burden than normal-weight asthma among Hispanics. Adiposity, metabolic dysregulation, and inflammation are all implicated in pathogenesis of obesity-related asthma, but their independent contributions are poorly understood. Objective: To examine the independent contributions of body fat distribution, metabolic abnormalities and inflammation on asthma symptoms and pulmonary function among Hispanics. Methods: Participants of the Hispanic Community Health Study/Study of Latinos with doctor-diagnosed asthma who completed an asthma symptom questionnaire and performed a valid spirometry were included in the analysis (n = 1126). Multivariate analysis was used to examine the independent association of general adiposity (assessed using body mass index), truncal adiposity (assessed by waist circumference), metabolic dysregulation (presence of insulin resistance and low HDL) and inflammation (high-sensitivity C-Reactive Protein≥3 mg/L) with reported asthma symptoms or pulmonary function measures (FEV1, and FVC) while adjusting for demographic and clinical covariates. Results: Of the 1126 participants, 334 (29.5%) were overweight, and 648 (57.8%) were obese. FEV1 and FVC were lower in obese compared to normal-weight asthmatics. In analyses controlling for metabolic and adiposity factors, high hs-CRP (>7 mg/L) was associated with more symptoms (prevalence-ratio 1.27 (95%CI 1.05, 1.54), and lower FVC (β −138 ml (95%CI -27 ml, −249 ml)) and FEV1 (β −155 ml (95% CI -38 ml, −272 ml). Low HDL was also associated with lower FVC (β −111 ml (−22 ml, −201 ml) and FEV1 (β −100 ml (−12 ml, −188 ml)). Results were similar in men and women. Conclusions: Our findings suggest that hs-CRP and low HDL, rather than general and truncal adiposity, are associated with asthma burden among overweight and obese Hispanic adults.